# A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder

> **NCT06710431** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Afasci Inc** · enrollment: 36 (estimated)

## Conditions studied

- Alcohol Abuse
- Alcohol Abuse/addiction
- Anxiety
- Pain Threshold
- Depression Disorders
- Sleep Disorder

## Interventions

- **DRUG:** AFA-281

## Key facts

- **NCT ID:** NCT06710431
- **Lead sponsor:** Afasci Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06710431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06710431, "A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06710431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*